Third Dose of mRNA Vaccine Declines After 4 Months

The waning effectiveness of the third dose of mRNA COVID-19 vaccine has been studied. Waning immunity was observed during both the Delta and Omicron variant.

The waning effectiveness of the third dose of mRNA COVID-19 vaccine has been studied.

Although protection decreased with time, a third dose was still highly effective at preventing severe illness with Covid-19.

COVID-19 Vaccination in India: Issues and Challenges
India’s COVID-19 vaccination program has been launched. It currently uses the vaccines Covishield and Covaxin. There are some issues and challenges that need to be overcome in order to vaccinate all Indians.

‘Waning immunity was observed during both the Delta and Omicron variant waves in similar fashion to how mRNA vaccine effectiveness wanes after a second dose.’

"The mRNA vaccines, including the booster shot, are very effective, but effectiveness declines over time," said co-author Brian Dixon from the Indiana University.

"Our findings suggest that additional doses may be necessary to maintain protection against Covid-19, especially for high-risk populations."

Overall, the study reported that individuals with second and third doses of an mRNA vaccine had greater protection against hospitalisations (severe disease) than against emergency department/urgent care (ED/UC) visits (symptoms which may not require hospitalisation).

COVID-19 Vaccination Does Not Affect Fertility or Early Pregnancy
New study findings add to the growing body of evidence that provides reassurance that COVID-19 vaccination does not affect fertility.

Vaccine effectiveness was also lower overall during the Omicron period than during the Delta period.

Vaccine effectiveness against ED/UC visits declined from 97 per cent within the first two months of receipt of a booster to 89 per cent effectiveness at four months or more during the Delta-predominant period (summer/early fall 2021).

Omicron Variant Raises Death Rates Despite COVID-19 Vaccination
Outbreak of the new Omicron variant has resulted in a massive surge of the COVID-19 cases alongside the rising number of COVID-related fatalities despite vaccination.

During the Omicron-predominant period (late fall 2021/winter 2021-22), vaccine effectiveness against ED/UC visits was 87 per cent during the first two months after a third dose, decreasing to 66 per cent at four months after a third dose.

After the third dose, protection against Delta variant-associated hospitalisation declined from 96 per cent within two months to 76 per cent after four months or longer.

COVID-19 Vaccination in India: Over 3 Crore Teens Jabbed With First Dose of Vaccine
Since the start of the vaccination drive, over three crore teenagers between the ages 15 and 18 years have been vaccinated with the first dose.

Vaccine effectiveness against Omicron variant-associated hospitalisations was 91 per cent during the first two months declining to 78 per cent at four months.

Source-IANS